These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26081380)

  • 1. [Current Treatment of Stable Angina].
    Toggweiler S; Jamshidi P; Cuculi F
    Praxis (Bern 1994); 2015 Jun; 104(13):681-7. PubMed ID: 26081380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of stable angina pectoris.
    Palaniswamy C; Aronow WS
    Am J Ther; 2011 Sep; 18(5):e138-52. PubMed ID: 20861717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evidence-based optimal treatment strategy of patients with angina pectoris].
    Jánosi A
    Orv Hetil; 2008 Feb; 149(7):293-8. PubMed ID: 18258559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and Management of Stable Angina: A Review.
    Joshi PH; de Lemos JA
    JAMA; 2021 May; 325(17):1765-1778. PubMed ID: 33944871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stable angina: current state of disease management.
    Dobesh PP
    J Manag Care Pharm; 2006 Oct; 12(8 Suppl):S4-9. PubMed ID: 23577422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of uncontrolled cardiovascular risk factors in patients treated with percutaneous interventions for stable coronary artery disease not receiving cardiac rehabilitation.
    Khattab AA; Knecht M; Meier B; Windecker S; Schmid JP; Wilhelm M; Saner H
    Eur J Prev Cardiol; 2013 Oct; 20(5):743-9. PubMed ID: 22547410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: a report from the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation 2 Diabetes).
    Tamis-Holland JE; Lu J; Korytkowski M; Magee M; Rogers WJ; Lopes N; Mighton L; Jacobs AK;
    J Am Coll Cardiol; 2013 Apr; 61(17):1767-76. PubMed ID: 23500245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What constitutes an appropriate empirical trial of antianginal therapy in patients with stable angina before referral for revascularisation?
    Boden WE; Kaski JC; Al-Lamee R; Weintraub WS
    Lancet; 2022 Feb; 399(10325):691-694. PubMed ID: 35033221
    [No Abstract]   [Full Text] [Related]  

  • 10. [Coronary revascularization versus optimal medical therapy in elderly patients with stable multivessel disease].
    Bogachev AA; Kozlov KL; Oleksiuk IB
    Adv Gerontol; 2011; 24(4):650-7. PubMed ID: 22550874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic considerations in managing patients with chronic stable angina.
    Nutescu EA
    J Manag Care Pharm; 2006 Oct; 12(8 Suppl):S17-21. PubMed ID: 23577424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stable angina pectoris: the medical management of symptomatic myocardial ischemia.
    Parker JD; Parker JO
    Can J Cardiol; 2012; 28(2 Suppl):S70-80. PubMed ID: 22424287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable angina pectoris: current medical treatment.
    Siama K; Tousoulis D; Papageorgiou N; Siasos G; Tsiamis E; Bakogiannis C; Briasoulis A; Androulakis E; Tentolouris K; Stefanadis C
    Curr Pharm Des; 2013; 19(9):1569-80. PubMed ID: 23016717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controversies in cardiovascular medicine: Chronic stable coronary artery disease: drugs vs. revascularization.
    Simoons ML; Windecker S
    Eur Heart J; 2010 Mar; 31(5):530-41. PubMed ID: 20106842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable angina pectoris.
    Valgimigli M; Biscaglia S
    Curr Atheroscler Rep; 2014 Jul; 16(7):422. PubMed ID: 24838374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revascularization versus medical treatments in stable coronary artery disease: predicting the future of novel drug therapies for stable angina.
    Risos L; Berkenboom G
    J Cardiovasc Pharmacol; 2014 Mar; 63(3):213-7. PubMed ID: 24336013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial.
    Teo KK; Sedlis SP; Boden WE; O'Rourke RA; Maron DJ; Hartigan PM; Dada M; Gupta V; Spertus JA; Kostuk WJ; Berman DS; Shaw LJ; Chaitman BR; Mancini GB; Weintraub WS;
    J Am Coll Cardiol; 2009 Sep; 54(14):1303-8. PubMed ID: 19778673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. RITA-2 trial participants.
    Lancet; 1997 Aug; 350(9076):461-8. PubMed ID: 9274581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal medical therapy and percutaneous coronary intervention for stable angina: why patients should 'be taking' and 'keep taking' the tablets.
    Mohee K; Wheatcroft SB
    J Clin Pharm Ther; 2014 Aug; 39(4):331-3. PubMed ID: 24754310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.